ANI Pharmaceuticals Launches Misoprostol Tablets
13 April 2022 - - US-based biopharmaceutical company ANI Pharmaceuticals, Inc (NASDAQ: ANIP) has launched Misoprostol Tablets, 100 mcg and 200 mcg, the company said.

ANI's Misoprostol Tablets are the generic version of the Reference Listed Drug Cytotec.

The current annual US market for Misoprostol Tablets, 100 mcg and 200 mcg is approximately USD 15.3m, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

ANI Pharmaceuticals is in developing, manufacturing, and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need.

Its team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening its generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities.